Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
MalariaSickle Cell Crisis
Interventions
DRUG

Proguanil

Proguanil tablets, 1.5mg/kg/day

DRUG

mefloquine plus artesunate

This treatment is given once a day for 3 days. Patients weighing 5-8 kg receive one paediatric tablet per day, those weighing 9-17 kg two paediatric tablets, those weighing 18-29 kg one adult tablet and those weighing 30 kg and two adult tablets.

DRUG

Sulfadoxine-pyrimethamine plus amodiaquine

amodiaquine plus sulfadoxine-pyrimethamine supervised at each bimonthly clinic visit (amodiaquine 10mg/kg per day for three days and sulfadoxine-pyrimethamine (25/1.25 mg/kg) on the first day).

Trial Locations (1)

Unknown

Department of Paediatrics and Child Health, University of Ilorin Teaching Hospital, Ilorin

All Listed Sponsors
collaborator

Medical Research Council Unit, The Gambia

OTHER

collaborator

Wellcome Trust

OTHER

collaborator

University of Ilorin Teaching Hospital

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01319448 - Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease | Biotech Hunter | Biotech Hunter